Wall Street Zen upgrades Genpact stock 5.56 percent below USD 39.33 on October 16

Published on 10/17/2026 at 20:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genpact's 52-week high is USD 48.64 on October 16, 2026. Genpact stock costs USD 37.26 on October 16, 2026, down 0.88 percent on Nasdaq.

Analyst target and trading range

Wall Street Zen upgraded Genpact from Hold to Buy on October 3, 2026, while the consensus target was USD 39.33.
Genpact's 52-week high was USD 48.64 on October 16, 2026.
Genpact stock last stood at USD 37.26 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 0.88 percent on the day.
Genpact is scheduled to report third-quarter 2026 results on November 5, 2026.

Genpact, BMG3922B1072, Illustration mit AI erstellt.

Wall Street Zen upgraded Genpact from Hold to Buy on October 3, 2026, while MarketBeat reported a consensus target of USD 39.33. That target stands 5.56 percent above Genpact's USD 37.26 Nasdaq price. Genpact last stood at USD 37.26 on October 16, 2026 at 4:00 p.m. ET, down 0.88 percent on the day.

Trading range sets the frame

Genpact traded between USD 26.85 and USD 48.64 over the 52 weeks ending October 16, 2026. The latest price was 23.40 percent below the high and 38.77 percent above the low, giving investors a clearer measure of its position than the daily move alone.

Turnover stayed below average

The October 16 session range ran from USD 36.62 to USD 38.40. Volume was 1,815,597 shares against an average of 2,139,279, so turnover reached 84.87 percent of the average. Genpact's 52-week high of USD 48.64 and low of USD 26.85 came from the same market context reported by MarketBeat.

Valuation and the next report

Genpact had a market capitalization of USD 6.3 billion, a price-to-earnings ratio of 11.06 and a dividend yield of 0.02 percent as of October 16, 2026. The valuation picture is paired with a near-term reporting date rather than a new corporate announcement.

Genpact is scheduled to report third-quarter 2026 results on November 5, 2026, after the market close, according to StockTitan. The scheduled release is the next dated event for the stock.

Comparison with peers

Genpact: minus 0.88 percent, P/E 11.06, market capitalization USD 6.3 billion.

International Business Machines (NYSE, USD): minus 0.85 percent, P/E 20.54, market capitalization USD 218.7 billion.

Accenture (NYSE, USD): plus 2.12 percent, P/E 16.94, market capitalization USD 140.6 billion.

Stock position before the next report

Genpact's USD 37.26 price leaves it below the 52-week high while the consensus target remains USD 39.33. The next scheduled results date is November 5, 2026.

Market context: Market report S&P 500.

More news and analyses on Genpact stock